Lutronic Genius
RF Microneedling · Real-time impedance-feedback RF microneedling
The Lutronic Genius typically sells new in the $35k–$55k range in the US, with used and refurbished systems around $20k–$35k. Lutronic Genius holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: RF electrosurgical system — electrocoagulation and hemostasis in dermatologic/general surgery
Last verified: August 6, 2026 · How we verify
New: $35k–$55k|Used: $20k–$35kmarket estimate, no email required
| Manufacturer | Lutronic |
|---|---|
| Company | Owner: Hahn & Company (South Korean private equity) (private equity owned, since 2024) · Distribution: direct |
| Category | RF Microneedling, Tightening & HIFU |
| Technology | Real-time impedance-feedback RF microneedling |
| FDA status | FDA Cleared |
| New price range | $35k–$55k |
| Used price range | $20k–$35k |
| Consumables | Not published |
| Launch year | 2019 |
| Last verified | August 6, 2026 |
Bottom line
The RF microneedling device injectors quietly respect — the successor to Infini, with real impedance-sensing that actually delivers the energy it says it delivers, which is why derms doing acne-scar and laxity work pick it over flashier competitors. It lacks Morpheus8's consumer name recognition, so you'll market the treatment, not the machine. Roughly $80k-120k new depending on negotiation and trade-ins. Buy it if outcomes and repeat clinical business matter more than Instagram hashtag volume.
Overview
Infini successor with coagulation feedback
How it works
The science
Insulated gold-plated microneedles (49-pin cartridge) penetrate to a set depth (0.2-3.5mm) and deliver bipolar RF directly into the dermis, creating controlled coagulation zones that trigger new collagen and elastin while sparing the epidermis. Because energy comes from RF, not light, it's safe across all Fitzpatrick types, including tones where aggressive lasers risk hyperpigmentation. Core uses: acne scarring, face/neck laxity, texture, crepey lower face, off-face body areas. Typical protocol stacks 2-3 depth passes per session so multiple dermal layers are treated in one sitting.
Patented tech
Real-time impedance feedback ("Intelligent RF"): the system continuously measures tissue resistance during each pulse and adjusts output so the joules displayed are the joules actually delivered — total energy per treatment is tracked, letting providers dose reproducibly instead of guessing. The handpiece motor gives smoother needle insertion than the older Infini.
Origin
Lutronic, South Korea; US distribution under Cynosure Lutronic since the 2024 merger.
FDA & regulatory status
What it's actually cleared for:
RF electrosurgical system — electrocoagulation and hemostasis in dermatologic/general surgery
510(k) numbers
K180945
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Recent industry events
How we source company dataOwnership and corporate changes at Lutronic that can affect warranty, service and parts availability.
- Jan 2024
Cynosure and Lutronic merge under Hahn & Company
MergerCynosure and Lutronic announced their merger on January 19, 2024, closing later that year to form Cynosure Lutronic, Inc. under South Korean private equity firm Hahn & Company; terms undisclosed. This followed CD&R's 2019 purchase of Cynosure from Hologic for $205M and Hahn's 2023 acquisition of Lutronic.
Source: PR Newswire (Jan 19, 2024); Hologic filings
Treatment economics
What practices charge
$800-1,500 per full-face session, face-and-neck $1,200-1,800 in major metros. Standard course 3 sessions 4-6 weeks apart, packaged $2,400-4,500. Acne-scar patients frequently buy annual maintenance.
Consumables & recurring cost
Single-use 49-needle cartridges ~$100-175 each, one per treatment. At 10-15 treatments/month: $15k-25k/year in tips — margin works at $1,000+ per session; discounting below ~$600 gets thin. Gray-market tips can void support — budget for OEM.
Ideal for
Best-fit practice
Derm- or plastics-adjacent medspas with a clinical reputation and patients seeking acne scar revision, tightening, and treatments safe for darker skin. Demographic spans the scar-revision segment (20s-40s, all tones) and the laxity segment (45+). Weak fit for a discount-facial spa whose clients balk at four-figure tickets.
Compliance
Medical director & delegation
Class II RF electrosurgical device; most states allow delegation to RNs/NPs/PAs under a supervising physician, but rules vary significantly — verify with your board.
Contraindications & screening
Pacemakers/implanted electronics, metal implants in the area, active infection or acne flare, isotretinoin within 6 months (practice-dependent), pregnancy, keloid history, impaired healing.
Ownership
Warranty & service
1-year standard; extended $8k-15k/year through Cynosure Lutronic; post-merger service reorganization has produced mixed field reviews on response times — get terms in writing.
Resale & used market
Strong for the category — Genius holds value better than most RF-MN because clinical demand is steady; used $35k-60k depending on year and tip eligibility. Buyers scrutinize OEM tip/service eligibility.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
Head-to-head comparisons buyers ask for
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 5, 2026
FDA K-numbers
K180945; K253484 → K180945
Source: Automatic record update
August 5, 2026
FDA indication
RF microneedling cleared for electrocoagulation and hemostasis in dermatologic and general surgical procedures → RF electrosurgical system — electrocoagulation and hemostasis in dermatologic/general surgery
Source: Automatic record update
August 5, 2026
FDA K-numbers
K180945 → K180945; K253484
Source: Automatic record update
August 5, 2026
FDA indication
RF electrosurgical system — electrocoagulation and hemostasis in dermatologic/general surgery → RF microneedling cleared for electrocoagulation and hemostasis in dermatologic and general surgical procedures
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.